Nádorové markery v diagnostice nádorů podjaterní krajiny
[Tumor markers in the diagnosis of tumors in the subhepatic area]
Language Czech Country Czech Republic Media print
Document type English Abstract, Journal Article
PubMed
8073643
- MeSH
- Antigens, Neoplasm analysis MeSH
- Antigens, Tumor-Associated, Carbohydrate analysis MeSH
- Cholangiocarcinoma diagnosis MeSH
- Adult MeSH
- Carcinoembryonic Antigen analysis MeSH
- Middle Aged MeSH
- Humans MeSH
- Biomarkers, Tumor analysis MeSH
- Pancreatic Neoplasms diagnosis MeSH
- Bile Duct Neoplasms diagnosis MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Bile Ducts, Intrahepatic * MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Female MeSH
- Publication type
- English Abstract MeSH
- Journal Article MeSH
- Names of Substances
- Antigens, Neoplasm MeSH
- Antigens, Tumor-Associated, Carbohydrate MeSH
- DU-PAN-2 antigen, human MeSH Browser
- Carcinoembryonic Antigen MeSH
- Biomarkers, Tumor MeSH
Concentrations of CA 19-9, CA 50, CA 195 and DUPAN-2 were followed in serum, bile and pancreatic juice of 65 patients with malignant or benign lesions of CBD and/or pancrease. In sera, significant differences between neoplasias and benign lesions were seen only in patients with tumors in stages III. and IV. In the bile, however, the significant increase of DUPAN-2 and CA 195 were present in all stages of cholangiocarcinoma when compared with benign CBD lesions. In the pancreatic juice, the significant increase on of CA 19-9, CA 50 and DUPAN-2 in patients with pancreatic cancer (stages I-IV) could also be evidenced.
